Redeye: Stille - Growth continues, but slightly below estimates
Redeye returns with an updated assessment of Stille following its Q4 2022 report. We have a largely neutral take on the report which came in slightly below our estimates.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/